<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39469708</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Immune and non-immune mediators in the fibrosis pathogenesis of salivary gland in Sjögren's syndrome.</ArticleTitle><Pagination><StartPage>1421436</StartPage><MedlinePgn>1421436</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1421436</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1421436</ELocationID><Abstract><AbstractText>Sjögren's syndrome (SS) or Sjögren's disease (SjD) is a systemic autoimmune disease clinically manifested as sicca symptoms. This disease primarily impacts the functionality of exocrine glands, specifically the lacrimal and salivary glands (SG). SG fibrosis, an irreversible morphological change, is a severe consequence that occurs in the later stages of the disease due to sustained inflammation. However, the mechanism underlying SG fibrosis in SS remains under-investigated. Glandular fibrosis may arise from chronic sialadenitis, in which the interactions between infiltrating lymphocytes and epithelial cells potentially contributes to fibrotic pathogenesis. Thus, both immune and non-immune cells are closely involved in this process, while their interplays are not fully understood. The molecular mechanism of tissue fibrosis is partly associated with an imbalance of immune responses, in which the transforming growth factor-beta (TGF-β)-dependent epithelial-mesenchymal transition (EMT) and extracellular matrix remodeling are recently investigated. In addition, viral infection has been implicated in the pathogenesis of SS. Viral-specific innate immune response could exacerbate the autoimmune progression, resulting in overt inflammation in SG. Notably, post-COVID patients exhibit typical SS symptoms and severe inflammatory sialadenitis, which are positively correlated with SG damage. In this review, we discuss the immune and non-immune risk factors in SG fibrosis and summarize the evidence to understand the mechanisms upon autoimmune progression in SS.</AbstractText><CopyrightInformation>Copyright © 2024 Ma, Feng and Lin.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Danbao</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Chinese Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Chinese Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chinese Medicine, the University of Hong Kong-Shenzhen Hospital (HKU-SZH), Shenzhen, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D012859" MajorTopicYN="Y">Sjogren's Syndrome</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012469" MajorTopicYN="Y">Salivary Glands</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005355" MajorTopicYN="Y">Fibrosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058750" MajorTopicYN="N">Epithelial-Mesenchymal Transition</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012793" MajorTopicYN="N">Sialadenitis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Sjögren’s disease (SjD)</Keyword><Keyword MajorTopicYN="N">Sjögren’s syndrome</Keyword><Keyword MajorTopicYN="N">epithelial-mesenchymal transition</Keyword><Keyword MajorTopicYN="N">extracellular matrix remodeling</Keyword><Keyword MajorTopicYN="N">fibrosis</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">salivary gland</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>10</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>10</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>4</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39469708</ArticleId><ArticleId IdType="pmc">PMC11513355</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1421436</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brito-Zerón P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, et al. . Sjögren syndrome. Nat Rev Dis Primers. (2016) 2:16047. doi: 10.1038/nrdp.2016.47</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2016.47</ArticleId><ArticleId IdType="pubmed">27383445</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Ren H, Meng F, Li J, Cheung E, Li H, et al. . Pathological roles of interleukin-22 in the development of recurrent hepatitis C after liver transplantation. PloS One. (2016) 11:e0154419. doi: 10.1371/journal.pone.0154419</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0154419</ArticleId><ArticleId IdType="pmc">PMC4849629</ArticleId><ArticleId IdType="pubmed">27123854</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, Xie W, Geng Y, Fan Y, Zhang Z. Mortality in patients with primary Sjogren's syndrome: A systematic review and meta-analysis. Rheumatol (Oxford). (2021) 60:4029–38. doi: 10.1093/rheumatology/keab364</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keab364</ArticleId><ArticleId IdType="pubmed">33878179</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher BA, Jonsson R, Daniels T, Bombardieri M, Brown RM, Morgan P, et al. . Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome. Ann Rheum Dis. (2017) 76:1161–8. doi: 10.1136/annrheumdis-2016-210448</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2016-210448</ArticleId><ArticleId IdType="pmc">PMC5530351</ArticleId><ArticleId IdType="pubmed">27965259</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckes B, Eming SA. Tissue fibrosis: A pathomechanistically unresolved challenge and scary clinical problem. Exp Dermatol. (2017) 26:135–6. doi: 10.1111/exd.13165</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/exd.13165</ArticleId><ArticleId IdType="pubmed">27513440</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao R, Yang HT, Li H, Liu LX, Li K, Li JJ, et al. . Recent advances of salivary gland biopsy in Sjögren's syndrome. Front Med (Lausanne). (2021) 8:792593. doi: 10.3389/fmed.2021.792593</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.792593</ArticleId><ArticleId IdType="pmc">PMC8784519</ArticleId><ArticleId IdType="pubmed">35083248</ArticleId></ArticleIdList></Reference><Reference><Citation>Bookman AA, Shen H, Cook RJ, Bailey D, McComb RJ, Rutka JA, et al. . Whole stimulated salivary flow: correlation with the pathology of inflammation and damage in minor salivary gland biopsy specimens from patients with primary Sjögren's syndrome but not patients with sicca. Arthritis Rheum. (2011) 63:2014–20. doi: 10.1002/art.30295</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.30295</ArticleId><ArticleId IdType="pubmed">21337320</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K-A, Kim S-H, Kim H-R, Kim H-S. Impact of age on the diagnostic performance of unstimulated salivary flow rates and salivary gland ultrasound for primary Sjögren's syndrome. Front Med. (2022) 9:968697. doi: 10.3389/fmed.2022.968697</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.968697</ArticleId><ArticleId IdType="pmc">PMC9630639</ArticleId><ArticleId IdType="pubmed">36341231</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Ye Y, Wu Y, Li L, Hu J, Luo D, et al. . Alterations in histology of the aging salivary gland and correlation with the glandular inflammatory microenvironment. iScience. (2023) 26:106571. doi: 10.1016/j.isci.2023.106571</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.106571</ArticleId><ArticleId IdType="pmc">PMC10131127</ArticleId><ArticleId IdType="pubmed">37124415</ArticleId></ArticleIdList></Reference><Reference><Citation>Syrjänen S. Age-related changes in structure of labial minor salivary glands. Age Ageing. (1984) 13:159–65. doi: 10.1093/ageing/13.3.159</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/13.3.159</ArticleId><ArticleId IdType="pubmed">6731173</ArticleId></ArticleIdList></Reference><Reference><Citation>Llamas-Gutierrez FJ, Reyes E, Martínez B, Hernández-Molina G. Histopathological environment besides the focus score in Sjögren's syndrome. Int J Rheum Dis. (2014) 17:898–903. doi: 10.1111/1756-185x.12502</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185x.12502</ArticleId><ArticleId IdType="pubmed">25293642</ArticleId></ArticleIdList></Reference><Reference><Citation>Leehan KM, Pezant NP, Rasmussen A, Grundahl K, Moore JS, Radfar L, et al. . Minor salivary gland fibrosis in Sjögren's syndrome is elevated, associated with focus score and not solely a consequence of aging. Clin Exp Rheumatol. (2018) 36 Suppl 112:80–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5913007</ArticleId><ArticleId IdType="pubmed">29148407</ArticleId></ArticleIdList></Reference><Reference><Citation>Joachims ML, Leehan KM, Lawrence C, Pelikan RC, Moore JS, Pan Z, et al. . Single-cell analysis of glandular T cell receptors in Sjögren's syndrome. JCI Insight. (2016) 1(8):e85609. doi: 10.1172/jci.insight.85609</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.85609</ArticleId><ArticleId IdType="pmc">PMC4922426</ArticleId><ArticleId IdType="pubmed">27358913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni PP, Solomon B, Hsieh CS, Allen PM, Morris GP. The ability to rearrange dual TCRs enhances positive selection, leading to increased allo- and autoreactive T cell repertoires. J Immunol. (2014) 193:1778–86. doi: 10.4049/jimmunol.1400532</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1400532</ArticleId><ArticleId IdType="pmc">PMC4119549</ArticleId><ArticleId IdType="pubmed">25015825</ArticleId></ArticleIdList></Reference><Reference><Citation>Goules AV, Kapsogeorgou EK, Tzioufas AG. Insight into pathogenesis of Sjögren's syndrome: dissection on autoimmune infiltrates and epithelial cells. Clin Immunol. (2017) 182:30–40. doi: 10.1016/j.clim.2017.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2017.03.007</ArticleId><ArticleId IdType="pubmed">28330683</ArticleId></ArticleIdList></Reference><Reference><Citation>Joachims ML, Leehan KM, Dozmorov MG, Georgescu C, Pan Z, Lawrence C, et al. . Sjögren's syndrome minor salivary gland CD4(+) memory T cells associate with glandular disease features and have a germinal center T follicular helper transcriptional profile. J Clin Med. (2020) 9(7):2164. doi: 10.3390/jcm9072164</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9072164</ArticleId><ArticleId IdType="pmc">PMC7408878</ArticleId><ArticleId IdType="pubmed">32650575</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng L, Huang T, Zhang L. T cells in idiopathic pulmonary fibrosis: crucial but controversial. Cell Death Discovery. (2023) 9:62. doi: 10.1038/s41420-023-01344-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-023-01344-x</ArticleId><ArticleId IdType="pmc">PMC9929223</ArticleId><ArticleId IdType="pubmed">36788232</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. (2008) 214:199–210. doi: 10.1002/path.2277</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2277</ArticleId><ArticleId IdType="pmc">PMC2693329</ArticleId><ArticleId IdType="pubmed">18161745</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Y, Liu Z, Jallal B, Shen N, Rönnblom L. Type I interferons in Sjögren's syndrome. Autoimmun Rev. (2013) 12:558–66. doi: 10.1016/j.autrev.2012.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2012.10.006</ArticleId><ArticleId IdType="pubmed">23201923</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong SM, Lee J, Jang SG, Lee J, Cho ML, Kwok SK, et al. . Type I interferon increases inflammasomes associated pyroptosis in the salivary glands of patients with primary Sjögren's syndrome. Immune Netw. (2020) 20:e39. doi: 10.4110/in.2020.20.e39</Citation><ArticleIdList><ArticleId IdType="doi">10.4110/in.2020.20.e39</ArticleId><ArticleId IdType="pmc">PMC7609163</ArticleId><ArticleId IdType="pubmed">33163247</ArticleId></ArticleIdList></Reference><Reference><Citation>Szczerba BM, Rybakowska PD, Dey P, Payerhin KM, Peck AB, Bagavant H, et al. . Type I interferon receptor deficiency prevents murine Sjogren's syndrome. J Dent Res. (2013) 92:444–9. doi: 10.1177/0022034513483315</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022034513483315</ArticleId><ArticleId IdType="pmc">PMC3627507</ArticleId><ArticleId IdType="pubmed">23533183</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsias DI, Tzioufas AG, Veiopoulou C, Zintzaras E, Tassios IK, Kogopoulou O, et al. . The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome. Clin Exp Immunol. (2002) 128:562–8. doi: 10.1046/j.1365-2249.2002.01869.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.2002.01869.x</ArticleId><ArticleId IdType="pmc">PMC1906267</ArticleId><ArticleId IdType="pubmed">12067313</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza TR, de Albuquerque Tavares Carvalho A, Duarte ÂP, Porter SR, Leão JC, Gueiros LA. Th1 and Th2 polymorphisms in Sjögren's syndrome and rheumatoid arthritis. J Oral Pathol Med. (2014) 43:418–26. doi: 10.1111/jop.12149</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jop.12149</ArticleId><ArticleId IdType="pubmed">24393164</ArticleId></ArticleIdList></Reference><Reference><Citation>Witas R, Gupta S, Nguyen CQ. Contributions of major cell populations to Sjögren's syndrome. J Clin Med. (2020) 9(9):3057. doi: 10.3390/jcm9093057</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9093057</ArticleId><ArticleId IdType="pmc">PMC7564211</ArticleId><ArticleId IdType="pubmed">32971904</ArticleId></ArticleIdList></Reference><Reference><Citation>van Woerkom JM, Kruize AA, Wenting-van Wijk MJ, Knol E, Bihari IC, Jacobs JW, et al. . Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome. Ann Rheum Dis. (2005) 64:1474–9. doi: 10.1136/ard.2004.031781</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2004.031781</ArticleId><ArticleId IdType="pmc">PMC1755251</ArticleId><ArticleId IdType="pubmed">15817659</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafa W, Zhu J, Deng G, Diab A, Link H, Frithiof L, et al. . Augmented levels of macrophage and Th1 cell-related cytokine mRNA in submandibular glands of MRL/lpr mice with autoimmune sialoadenitis. Clin Exp Immunol. (1998) 112:389–96. doi: 10.1046/j.1365-2249.1998.00609.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.1998.00609.x</ArticleId><ArticleId IdType="pmc">PMC1905000</ArticleId><ArticleId IdType="pubmed">9649206</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenwell-Wild T, Moutsopoulos NM, Gliozzi M, Kapsogeorgou E, Rangel Z, Munson PJ, et al. . Chitinases in the salivary glands and circulation of patients with Sjögren's syndrome: macrophage harbingers of disease severity. Arthritis Rheum. (2011) 63:3103–15. doi: 10.1002/art.30465</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.30465</ArticleId><ArticleId IdType="pmc">PMC3183169</ArticleId><ArticleId IdType="pubmed">21618203</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Zhang X, Shi X, Liu Y, Cheng D, Tian Q, et al. . CXCL9, 10, 11/CXCR3 axis contributes to the progress of primary Sjogren's syndrome by activating GRK2 to promote T lymphocyte migration. Inflammation. (2023) 46:1047–60. doi: 10.1007/s10753-023-01791-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-023-01791-9</ArticleId><ArticleId IdType="pubmed">36801996</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruffilli I. Sjögren's syndrome and chemokines. Clin Ter. (2014) 165:e464–9. doi: 10.7417/ct.2014.1793</Citation><ArticleIdList><ArticleId IdType="doi">10.7417/ct.2014.1793</ArticleId><ArticleId IdType="pubmed">25524206</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa N, Ping L, Zhenjun L, Takada Y, Sugai S. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome. Arthritis Rheum. (2002) 46:2730–41. doi: 10.1002/art.10577</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.10577</ArticleId><ArticleId IdType="pubmed">12384933</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa H, Inoue A, Kohno M, Muraoka M, Miyazaki T, Terada M, et al. . Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice. Arthritis Rheum. (2006) 54:1174–83. doi: 10.1002/art.21745</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.21745</ArticleId><ArticleId IdType="pubmed">16575871</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Gade P, Xiao W, Kalvakolanu DV. The interferon signaling network and transcription factor C/EBP-beta. Cell Mol Immunol. (2007) 4:407–18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2782719</ArticleId><ArticleId IdType="pubmed">18163952</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao T, Zhou J, Liu Q, Mao T, Chen B, Wu Q, et al. . Interferon-gamma induces salivary gland epithelial cell ferroptosis in Sjogren's syndrome via JAK/STAT1-mediated inhibition of system Xc(). Free Radic Biol Med. (2023) 205:116–28. doi: 10.1016/j.freeradbiomed.2023.05.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2023.05.027</ArticleId><ArticleId IdType="pubmed">37286044</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vita S, Boiocchi M, Sorrentino D, Carbone A, Avellini C, Dolcetti R, et al. . Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome. Arthritis Rheum. (1997) 40:318–31. doi: 10.1002/art.1780400217</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400217</ArticleId><ArticleId IdType="pubmed">9041944</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriyama M, Hayashida JN, Toyoshima T, Ohyama Y, Shinozaki S, Tanaka A, et al. . Cytokine/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary sjögren's syndrome. Clin Exp Immunol. (2012) 169:17–26. doi: 10.1111/j.1365-2249.2012.04587.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2012.04587.x</ArticleId><ArticleId IdType="pmc">PMC3390469</ArticleId><ArticleId IdType="pubmed">22670774</ArticleId></ArticleIdList></Reference><Reference><Citation>Gieseck RL, Wilson MS, Wynn TA. Type 2 immunity in tissue repair and fibrosis. Nat Rev Immunol. (2018) 18:62–76. doi: 10.1038/nri.2017.90</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.90</ArticleId><ArticleId IdType="pubmed">28853443</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. (2016) 44:450–62. doi: 10.1016/j.immuni.2016.02.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2016.02.015</ArticleId><ArticleId IdType="pmc">PMC4794754</ArticleId><ArticleId IdType="pubmed">26982353</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendall RT, Feghali-Bostwick CA. Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol. (2014) 5:123. doi: 10.3389/fphar.2014.00123</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2014.00123</ArticleId><ArticleId IdType="pmc">PMC4034148</ArticleId><ArticleId IdType="pubmed">24904424</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasse GF, Nizamoglu M, Heijink IH, Schlepütz M, van Rijn P, Thomas MJ, et al. . Macrophage–stroma interactions in fibrosis: biochemical, biophysical, and cellular perspectives. J Pathol. (2021) 254:344–57. doi: 10.1002/path.5632</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5632</ArticleId><ArticleId IdType="pmc">PMC8252758</ArticleId><ArticleId IdType="pubmed">33506963</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesce J, Kaviratne M, Ramalingam TR, Thompson RW, Urban JF, Jr., Cheever AW, et al. . The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest. (2006) 116:2044–55. doi: 10.1172/jci27727</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci27727</ArticleId><ArticleId IdType="pmc">PMC1479424</ArticleId><ArticleId IdType="pubmed">16778988</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimitriou ID, Kapsogeorgou EK, Moutsopoulos HM, Manoussakis MN. CD40 on salivary gland epithelial cells: high constitutive expression by cultured cells from Sjögren's syndrome patients indicating their intrinsic activation. Clin Exp Immunol. (2002) 127:386–92. doi: 10.1046/j.1365-2249.2002.01752.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.2002.01752.x</ArticleId><ArticleId IdType="pmc">PMC1906327</ArticleId><ArticleId IdType="pubmed">11876766</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerstin K. Fibroblasts in Sjögren’s syndrome. In: Mojca Frank B, Katja L, editors. Fibroblasts. IntechOpen, Rijeka: (2021).</Citation></Reference><Reference><Citation>Barone F, Nayar S, Campos J, Cloake T, Withers DR, Toellner K-M, et al. . Il-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs. Proc Natl Acad Sci. (2015) 112:11024–9. doi: 10.1073/pnas.1503315112</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1503315112</ArticleId><ArticleId IdType="pmc">PMC4568258</ArticleId><ArticleId IdType="pubmed">26286991</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavoie TN, Stewart CM, Berg KM, Li Y, Nguyen CQ. Expression of interleukin-22 in Sjögren's syndrome: significant correlation with disease parameters. Scand J Immunol. (2011) 74:377–82. doi: 10.1111/j.1365-3083.2011.02583.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3083.2011.02583.x</ArticleId><ArticleId IdType="pmc">PMC3250060</ArticleId><ArticleId IdType="pubmed">21645026</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Onodera S, Hu Y, Yu Q. Interleukin-22 exerts detrimental effects on salivary gland integrity and function. Int J Mol Sci. (2022) 23(21):12997. doi: 10.3390/ijms232112997</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232112997</ArticleId><ArticleId IdType="pmc">PMC9655190</ArticleId><ArticleId IdType="pubmed">36361787</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccia F, Guggino G, Rizzo A, Ferrante A, Raimondo S, Giardina A, et al. . Potential involvement of IL-22 AND IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome. Ann Rheum Dis. (2012) 71:295–301. doi: 10.1136/ard.2011.154013</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2011.154013</ArticleId><ArticleId IdType="pubmed">21979002</ArticleId></ArticleIdList></Reference><Reference><Citation>Belle I, Mahlios J, McKenzie A, Zhuang Y. Aberrant production of IL-13 by T cells promotes exocrinopathy in Id3 knockout mice. Cytokine. (2014) 69:226–33. doi: 10.1016/j.cyto.2014.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2014.06.009</ArticleId><ArticleId IdType="pmc">PMC4127355</ArticleId><ArticleId IdType="pubmed">25010390</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Li X, Qian L, Wang G, Zhang H, Wang X, et al. . T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome. J Rheumatol. (2007) 34:2438–45.</Citation><ArticleIdList><ArticleId IdType="pubmed">18050367</ArticleId></ArticleIdList></Reference><Reference><Citation>Alunno A, Petrillo MG, Nocentini G, Bistoni O, Bartoloni E, Caterbi S, et al. . Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome. Rheumatol (Oxford). (2013) 52:1387–96. doi: 10.1093/rheumatology/ket179</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ket179</ArticleId><ArticleId IdType="pubmed">23674818</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisto M, Ribatti D, Lisi S. Organ fibrosis and autoimmunity: the role of inflammation in TGFβ-dependent EMT. Biomolecules. (2021) 11:310. doi: 10.3390/biom11020310</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11020310</ArticleId><ArticleId IdType="pmc">PMC7922523</ArticleId><ArticleId IdType="pubmed">33670735</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisto M, Lisi S, Ribatti D. The role of the epithelial-to-mesenchymal transition (EMT) in diseases of the salivary glands. Histochem Cell Biol. (2018) 150:133–47. doi: 10.1007/s00418-018-1680-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00418-018-1680-y</ArticleId><ArticleId IdType="pubmed">29789993</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Z, Wang L, Li X. Composition and regulation of the immune microenvironment of salivary gland in Sjögren’s syndrome. Front Immunol. (2022) 13:967304. doi: 10.3389/fimmu.2022.967304</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.967304</ArticleId><ArticleId IdType="pmc">PMC9513852</ArticleId><ArticleId IdType="pubmed">36177010</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisto M, Lorusso L, Tamma R, Ingravallo G, Ribatti D, Lisi S. Interleukin-17 and -22 synergy linking inflammation and EMT-dependent fibrosis in Sjögren's syndrome. Clin Exp Immunol. (2019) 198:261–72. doi: 10.1111/cei.13337</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13337</ArticleId><ArticleId IdType="pmc">PMC6797899</ArticleId><ArticleId IdType="pubmed">31165469</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisto M, Lorusso L, Ingravallo G, Tamma R, Ribatti D, Lisi S. The TGF-Β1 signaling pathway as an attractive target in the fibrosis pathogenesis of Sjögren's syndrome. Mediators Inflammation. (2018) 2018:1965935. doi: 10.1155/2018/1965935</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/1965935</ArticleId><ArticleId IdType="pmc">PMC6287147</ArticleId><ArticleId IdType="pubmed">30598637</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisto M, Ribatti D, Ingravallo G, Lisi S. The expression of follistatin-like 1 protein is associated with the activation of the EMT program in Sjögren's syndrome. J Clin Med. (2022) 11(18):5368. doi: 10.3390/jcm11185368</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11185368</ArticleId><ArticleId IdType="pmc">PMC9503234</ArticleId><ArticleId IdType="pubmed">36143013</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisto M, Tamma R, Ribatti D, Lisi S. Il-6 contributes to the TGF-Β1-mediated epithelial to mesenchymal transition in human salivary gland epithelial cells. Arch Immunol Ther Exp (Warsz). (2020) 68:27. doi: 10.1007/s00005-020-00591-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00005-020-00591-5</ArticleId><ArticleId IdType="pubmed">32914376</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisto M, Ribatti D, Lisi S. Understanding the complexity of Sjögren's syndrome: remarkable progress in elucidating NF-Κb mechanisms. J Clin Med. (2020) 9(9):2821. doi: 10.3390/jcm9092821</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9092821</ArticleId><ArticleId IdType="pmc">PMC7563658</ArticleId><ArticleId IdType="pubmed">32878252</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbi J, Pardoll D, Pan F. Metabolic control of the Treg/Th17 axis. Immunol Rev. (2013) 252:52–77. doi: 10.1111/imr.12029</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12029</ArticleId><ArticleId IdType="pmc">PMC3576873</ArticleId><ArticleId IdType="pubmed">23405895</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Xing Y, Gan Y, He J, Hua H. Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjögren's syndrome by modulating the balance of Treg and Th17 cells. Stem Cell Res Ther. (2021) 12:478. doi: 10.1186/s13287-021-02541-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-021-02541-0</ArticleId><ArticleId IdType="pmc">PMC8390194</ArticleId><ArticleId IdType="pubmed">34446113</ArticleId></ArticleIdList></Reference><Reference><Citation>Keindl M, Davies R, Bergum B, Brun JG, Hammenfors D, Jonsson R, et al. . Impaired activation of stat5 upon IL-2 stimulation in Tregs and elevated sIL-2R in Sjögren's syndrome. Arthritis Res Ther. (2022) 24:101. doi: 10.1186/s13075-022-02769-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-022-02769-y</ArticleId><ArticleId IdType="pmc">PMC9077945</ArticleId><ArticleId IdType="pubmed">35526080</ArticleId></ArticleIdList></Reference><Reference><Citation>Psianou K, Panagoulias I, Papanastasiou AD, de Lastic AL, Rodi M, Spantidea PI, et al. . Clinical and immunological parameters of Sjögren's syndrome. Autoimmun Rev. (2018) 17:1053–64. doi: 10.1016/j.autrev.2018.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2018.05.005</ArticleId><ArticleId IdType="pubmed">30103041</ArticleId></ArticleIdList></Reference><Reference><Citation>Fei Y, Zhang W, Lin D, Wu C, Li M, Zhao Y, et al. . Clinical parameter and Th17 related to lymphocytes infiltrating degree of labial salivary gland in primary Sjögren's syndrome. Clin Rheumatol. (2014) 33:523–9. doi: 10.1007/s10067-013-2476-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-013-2476-z</ArticleId><ArticleId IdType="pubmed">24420723</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawanami T, Sawaki T, Sakai T, Miki M, Iwao H, Nakajima A, et al. . Skewed production of IL-6 and TGFβ by cultured salivary gland epithelial cells from patients with Sjögren's syndrome. PloS One. (2012) 7:e45689. doi: 10.1371/journal.pone.0045689</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0045689</ArticleId><ArticleId IdType="pmc">PMC3484144</ArticleId><ArticleId IdType="pubmed">23118848</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X, Rui K, Deng J, Tian J, Wang X, Wang S, et al. . Th17 cells play a critical role in the development of experimental Sjögren's syndrome. Ann Rheum Dis. (2015) 74:1302–10. doi: 10.1136/annrheumdis-2013-204584</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-204584</ArticleId><ArticleId IdType="pubmed">24573745</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM. Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis. Am J Pathol. (2009) 175:1167–77. doi: 10.2353/ajpath.2009.090319</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2009.090319</ArticleId><ArticleId IdType="pmc">PMC2731135</ArticleId><ArticleId IdType="pubmed">19700754</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F, Du W, Zhu X, Tang Y, Liu L, Huang E, et al. . IL-17 drives salivary gland dysfunction via inhibiting TRPC1-mediated calcium movement in Sjögren's syndrome. Clin Transl Immunol. (2021) 10:e1277. doi: 10.1002/cti2.1277</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cti2.1277</ArticleId><ArticleId IdType="pmc">PMC8082715</ArticleId><ArticleId IdType="pubmed">33968407</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang LW, Zhou PR, Wei P, Cong X, Wu LL, Hua H. Expression of interleukin-17 in primary Sjögren's syndrome and the correlation with disease severity: A systematic review and meta-analysis. Scand J Immunol. (2018) 87:e12649. doi: 10.1111/sji.12649</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12649</ArticleId><ArticleId IdType="pubmed">29476557</ArticleId></ArticleIdList></Reference><Reference><Citation>Kartasheva-Ebertz D, Gaston J, Lair-Mehiri L, Mottez E, Buivan TP, Massault PP, et al. . IL-17a in human liver: significant source of inflammation and trigger of liver fibrosis initiation. Int J Mol Sci. (2022) 23(17):9773. doi: 10.3390/ijms23179773</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23179773</ArticleId><ArticleId IdType="pmc">PMC9456490</ArticleId><ArticleId IdType="pubmed">36077175</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F, Lin X, Tian J, Wang X, Chen Q, Rui K, et al. . Proteasome inhibition suppresses Th17 cell generation and ameliorates autoimmune development in experimental Sjögren's syndrome. Cell Mol Immunol. (2017) 14:924–34. doi: 10.1038/cmi.2017.8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2017.8</ArticleId><ArticleId IdType="pmc">PMC5675963</ArticleId><ArticleId IdType="pubmed">28690324</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccia F, Guggino G, Rizzo A, Alessandro R, Carubbi F, Giardina A, et al. . Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren’s syndrome. Rheumatology. (2014) 53:1313–20. doi: 10.1093/rheumatology/keu004</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keu004</ArticleId><ArticleId IdType="pubmed">24602921</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, et al. . Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. (2006) 203:2271–9. doi: 10.1084/jem.20061308</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20061308</ArticleId><ArticleId IdType="pmc">PMC2118116</ArticleId><ArticleId IdType="pubmed">16982811</ArticleId></ArticleIdList></Reference><Reference><Citation>Pipi E, Nayar S, Gardner DH, ColaFrancesco S, Smith C, Barone F. Tertiary lymphoid structures: autoimmunity goes local. Front Immunol. (2018) 9:1952. doi: 10.3389/fimmu.2018.01952</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01952</ArticleId><ArticleId IdType="pmc">PMC6143705</ArticleId><ArticleId IdType="pubmed">30258435</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogli LK, Sundrud MS, Goel S, Bajwa S, Jensen K, Derudder E, et al. . T cell-derived Il-17 mediates epithelial changes in the airway and drives pulmonary neutrophilia. J Immunol. (2013) 191(6):3100–11. doi: 10.4049/jimmunol.1301360</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1301360</ArticleId><ArticleId IdType="pmc">PMC3822005</ArticleId><ArticleId IdType="pubmed">23966625</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity. (2011) 34:149–62. doi: 10.1016/j.immuni.2011.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2011.02.012</ArticleId><ArticleId IdType="pubmed">21349428</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstappen GM, Corneth OBJ, Bootsma H, Kroese FGM. Th17 cells in primary Sjögren's syndrome: pathogenicity and plasticity. J Autoimmun. (2018) 87:16–25. doi: 10.1016/j.jaut.2017.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2017.11.003</ArticleId><ArticleId IdType="pubmed">29191572</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedroso R, Ribeiro F, Pires AR, Graca L, Fonseca VR. Identification of human T follicular cells in ectopic lymphoid structures. Methods Mol Biol. (2022) 2380:225–33. doi: 10.1007/978-1-0716-1736-6_19</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-1736-6_19</ArticleId><ArticleId IdType="pubmed">34802135</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokland SLM, van Vliet-Moret FM, Hillen MR, Pandit A, Goldschmeding R, Kruize AA, et al. . Epigenetically quantified immune cells in salivary glands of Sjögren's syndrome patients: A novel tool that detects robust correlations of T follicular helper cells with immunopathology. Rheumatol (Oxford). (2020) 59:335–43. doi: 10.1093/rheumatology/kez268</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kez268</ArticleId><ArticleId IdType="pmc">PMC7032543</ArticleId><ArticleId IdType="pubmed">31325310</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi J, Liu C, Bai Z, Li X, Yao G. T follicular helper cells and T follicular regulatory cells in autoimmune diseases. Front Immunol. (2023) 14:1178792. doi: 10.3389/fimmu.2023.1178792</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1178792</ArticleId><ArticleId IdType="pmc">PMC10175690</ArticleId><ArticleId IdType="pubmed">37187757</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca VR, Romão VC, Agua-Doce A, Santos M, López-Presa D, Ferreira AC, et al. . The ratio of blood T follicular regulatory cells to T follicular helper cells marks ectopic lymphoid structure formation while activated follicular helper T cells indicate disease activity in primary Sjögren's syndrome. Arthritis Rheumatol. (2018) 70:774–84. doi: 10.1002/art.40424</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40424</ArticleId><ArticleId IdType="pubmed">29361207</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadimitriou T-I, van Caam A, van der Kraan PM, Thurlings RM. Therapeutic options for systemic sclerosis: current and future perspectives in tackling immune-mediated fibrosis. Biomedicines. (2022) 10:316. doi: 10.3390/biomedicines10020316</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10020316</ArticleId><ArticleId IdType="pmc">PMC8869277</ArticleId><ArticleId IdType="pubmed">35203525</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisto M, Lisi S. Immune and non-immune inflammatory cells involved in autoimmune fibrosis: new discoveries. J Clin Med. (2023) 12:3801. doi: 10.3390/jcm12113801</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12113801</ArticleId><ArticleId IdType="pmc">PMC10253662</ArticleId><ArticleId IdType="pubmed">37297996</ArticleId></ArticleIdList></Reference><Reference><Citation>Pontarini E, Murray-Brown WJ, Croia C, Lucchesi D, Conway J, Rivellese F, et al. . Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren’s syndrome with ectopic germinal centres and malt lymphoma. Ann Rheumatic Dis. (2020) 79:1588–99. doi: 10.1136/annrheumdis-2020-217646</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217646</ArticleId><ArticleId IdType="pmc">PMC7677495</ArticleId><ArticleId IdType="pubmed">32963045</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen FY, Gaylord E, McNamara N, Knox S. Deciphering molecular and phenotypic changes associated with early autoimmune disease in the aire-deficient mouse model of Sjögren's syndrome. Int J Mol Sci. (2018) 19(11):3628. doi: 10.3390/ijms19113628</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19113628</ArticleId><ArticleId IdType="pmc">PMC6274681</ArticleId><ArticleId IdType="pubmed">30453645</ArticleId></ArticleIdList></Reference><Reference><Citation>Benchabane S, Boudjelida A, Toumi R, Belguendouz H, Youinou P, Touil-Boukoffa C. A case for IL-6, IL-17a, and nitric oxide in the pathophysiology of Sjögren's syndrome. Int J Immunopathol Pharmacol. (2016) 29:386–97. doi: 10.1177/0394632016651273</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0394632016651273</ArticleId><ArticleId IdType="pmc">PMC5806759</ArticleId><ArticleId IdType="pubmed">27207443</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei L, Xiong H, Li W, Li B, Cheng Y. Upregulation of IL-6 expression in human salivary gland cell line by IL-17 via activation of P38 MAPK, ERK, PI3K/Akt, and NF-ΚB pathways. J Oral Pathol Med. (2018) 47:847–55. doi: 10.1111/jop.12765</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jop.12765</ArticleId><ArticleId IdType="pubmed">30007092</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokland SLM, Hillen MR, Kruize AA, Meller S, Homey B, Smithson GM, et al. . Increased CCL25 and T helper cells expressing CCR9 in the salivary glands of patients with primary Sjögren's syndrome: potential new axis in lymphoid neogenesis. Arthritis Rheumatol. (2017) 69:2038–51. doi: 10.1002/art.40182</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40182</ArticleId><ArticleId IdType="pubmed">28622456</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer JM, Klimatcheva E, Rothstein TL. CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesis. J Leukoc Biol. (2013) 94:1079–89. doi: 10.1189/jlb.0113036</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0113036</ArticleId><ArticleId IdType="pmc">PMC3800060</ArticleId><ArticleId IdType="pubmed">23904442</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurosawa M, Shikama Y, Furukawa M, Arakaki R, Ishimaru N, Matsushita K. Chemokines up-regulated in epithelial cells control senescence-associated T cell accumulation in salivary glands of aged and Sjögren's syndrome model mice. Int J Mol Sci. (2021) 22(5):2302. doi: 10.3390/ijms22052302</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052302</ArticleId><ArticleId IdType="pmc">PMC7956724</ArticleId><ArticleId IdType="pubmed">33669065</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Molina G, Soto-Abraham V, Zamora-Legoff V, Furuzawa-Carballeda J. Differential Th follicular cell subsets in minor salivary glands of patients with primary Sjögren's syndrome and systemic lupus erythematosus associated with Sjögren's syndrome. Clin Exp Rheumatol. (2021) 39 Suppl 133:49–56. doi: 10.55563/clinexprheumatol/yuj21y</Citation><ArticleIdList><ArticleId IdType="doi">10.55563/clinexprheumatol/yuj21y</ArticleId><ArticleId IdType="pubmed">34596020</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F, Han M, Rui K, Ai X, Tian J, Zhang W, et al. . New insights into follicular helper T cell response and regulation in autoimmune pathogenesis. Cell Mol Immunol. (2021) 18:1610–2. doi: 10.1038/s41423-021-00688-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00688-7</ArticleId><ArticleId IdType="pmc">PMC8166848</ArticleId><ArticleId IdType="pubmed">33972739</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Yang J, Tian J, Wang S. CD8+ T lymphocytes: crucial players in Sjögren’s syndrome. Front Immunol. (2021) 11:602823. doi: 10.3389/fimmu.2020.602823</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.602823</ArticleId><ArticleId IdType="pmc">PMC7876316</ArticleId><ArticleId IdType="pubmed">33584670</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldeira-Dantas S, Furmanak T, Smith C, Quinn M, Teos LY, Ertel A, et al. . The Chemokine Receptor CXCR3 Promotes Cd8+ T Cell accumulation in uninfected salivary glands but is not necessary after murine cytomegalovirus infection. J Immunol. (2018) 200:1133–45. doi: 10.4049/jimmunol.1701272</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1701272</ArticleId><ArticleId IdType="pmc">PMC5780235</ArticleId><ArticleId IdType="pubmed">29288198</ArticleId></ArticleIdList></Reference><Reference><Citation>Goplen NP, Wu Y, Son YM, Li C, Wang Z, Cheon IS, et al. . Tissue-resident CD8(+) T cells drive age-associated chronic lung sequelae after viral pneumonia. Sci Immunol. (2020) 5(53):eabc4557. doi: 10.1126/sciimmunol.abc4557</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abc4557</ArticleId><ArticleId IdType="pmc">PMC7970412</ArticleId><ArticleId IdType="pubmed">33158975</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L, Zheng Z, Xiao F, Zhou Y, Zhong B, Ni Q, et al. . Single-cell clonal tracing of glandular and circulating T cells identifies a population of CD9+CD8+T cells in primary Sjogren's syndrome. J Leukoc Biol. (2023) 115(5):804–18. doi: 10.1093/jleuko/qiad071</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jleuko/qiad071</ArticleId><ArticleId IdType="pubmed">37395700</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauro D, Lin X, Guggino G, Chong D, Raimondo S, Ma D, et al. . Op0042 blocking of CD103+ Tissue resident memory T cells (TRM) as a therapeutic strategy in Sjogren’s syndrome. Ann Rheumatic Dis. (2021) 80:22–. doi: 10.1136/annrheumdis-2021-eular.2649</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-eular.2649</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao CY, Yao Y, Li L, Yang SH, Chu H, Tsuneyama K, et al. . Tissue-resident memory CD8+ T cells acting as mediators of salivary gland damage in a murine model of Sjögren's syndrome. Arthritis Rheumatol. (2019) 71:121–32. doi: 10.1002/art.40676</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40676</ArticleId><ArticleId IdType="pubmed">30035379</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Y, Yang W, Yang YQ, Ma HD, Lu FT, Li L, et al. . Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2rα(-/-) mice. J Autoimmun. (2014) 51:99–108. doi: 10.1016/j.jaut.2014.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2014.02.009</ArticleId><ArticleId IdType="pubmed">24651036</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyakh L, Trinchieri G, Provezza L, Carra G, Gerosa F. Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans. Immunol Rev. (2008) 226:112–31. doi: 10.1111/j.1600-065X.2008.00700.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2008.00700.x</ArticleId><ArticleId IdType="pmc">PMC2766610</ArticleId><ArticleId IdType="pubmed">19161420</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanke Y, Kobashigawa T, Yago T, Kawamoto M, Yamanaka H, Kotake S. Detection of IFN-Γ+IL-17+ Cells in salivary glands of patients with Sjögren's syndrome and Mikulicz's disease: potential role of Th17•Th1 in the pathogenesis of autoimmune diseases. Nihon Rinsho Meneki Gakkai Kaishi. (2016) 39:473–7. doi: 10.2177/jsci.39.473</Citation><ArticleIdList><ArticleId IdType="doi">10.2177/jsci.39.473</ArticleId><ArticleId IdType="pubmed">27795505</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen CQ, Hu MH, Li Y, Stewart C, Peck AB. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice. Arthritis Rheum. (2008) 58:734–43. doi: 10.1002/art.23214</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.23214</ArticleId><ArticleId IdType="pmc">PMC2850059</ArticleId><ArticleId IdType="pubmed">18311793</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu T, Zhu H-X, You X, Ma J-F, Li X, Luo P-Y, et al. . Single-cell profiling reveals pathogenic role and differentiation trajectory of granzyme K+CD8+ T cells in primary Sjögren’s syndrome. JCI Insight. (2023) 8(8):e167490. doi: 10.1172/jci.insight.167490</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.167490</ArticleId><ArticleId IdType="pmc">PMC10243796</ArticleId><ArticleId IdType="pubmed">36881472</ArticleId></ArticleIdList></Reference><Reference><Citation>Youinou P, Saraux A, Pers JO. B-lymphocytes govern the pathogenesis of Sjögren's syndrome. Curr Pharm Biotechnol. (2012) 13:2071–7. doi: 10.2174/138920112802273100</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920112802273100</ArticleId><ArticleId IdType="pubmed">22208653</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon TP, Bolstad AI, Rischmueller M, Jonsson R, Waterman SA. Autoantibodies in primary Sjögren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity. (2001) 34:123–32. doi: 10.3109/08916930109001960</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916930109001960</ArticleId><ArticleId IdType="pubmed">11905842</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein A, Klein J, Chacham M, Kleinman S, Shuster A, Peleg O, et al. . Acinar atrophy, fibrosis and fatty changes are significantly more common than Sjogren's syndrome in minor salivary gland biopsies. Medicina (Kaunas). (2022) 58(2):175. doi: 10.3390/medicina58020175</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58020175</ArticleId><ArticleId IdType="pmc">PMC8879368</ArticleId><ArticleId IdType="pubmed">35208499</ArticleId></ArticleIdList></Reference><Reference><Citation>van Ginkel MS, van der Sluis T, Bulthuis MLC, Buikema HJ, Haacke EA, Arends S, et al. . Digital image analysis of intraepithelial B-lymphocytes to assess lymphoepithelial lesions in salivary glands of Sjogren's syndrome patients. Rheumatol (Oxford). (2022) 62:428–38. doi: 10.1093/rheumatology/keac212</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keac212</ArticleId><ArticleId IdType="pmc">PMC9788820</ArticleId><ArticleId IdType="pubmed">35412585</ArticleId></ArticleIdList></Reference><Reference><Citation>Du W, Han M, Zhu X, Xiao F, Huang E, Che N, et al. . The multiple roles of B cells in the pathogenesis of Sjogren's syndrome. Front Immunol. (2021) 12:684999. doi: 10.3389/fimmu.2021.684999</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.684999</ArticleId><ArticleId IdType="pmc">PMC8217880</ArticleId><ArticleId IdType="pubmed">34168653</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstappen GM, Ice JA, Bootsma H, Pringle S, Haacke EA, de Lange K, et al. . Gene expression profiling of epithelium-associated FcRL4(+) B cells in primary Sjögren's syndrome reveals a pathogenic signature. J Autoimmun. (2020) 109:102439. doi: 10.1016/j.jaut.2020.102439</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102439</ArticleId><ArticleId IdType="pmc">PMC7337041</ArticleId><ArticleId IdType="pubmed">32201227</ArticleId></ArticleIdList></Reference><Reference><Citation>Daridon C, Pers JO, Devauchelle V, Martins-Carvalho C, Hutin P, Pennec YL, et al. . Identification of transitional type II B cells in the salivary glands of patients with Sjogren's syndrome. Arthritis Rheum. (2006) 54:2280–8. doi: 10.1002/art.21936</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.21936</ArticleId><ArticleId IdType="pubmed">16802367</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher CA, Sutherland AP, Groom JR, Batten ML, Ng LG, Gommerman J, et al. . Development of nephritis but not sialadenitis in autoimmune-prone baff transgenic mice lacking marginal zone B cells. Eur J Immunol. (2006) 36:2504–14. doi: 10.1002/eji.200636270</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200636270</ArticleId><ArticleId IdType="pubmed">16906535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanayama N, Cascalho M, Ohmori H. Analysis of marginal zone B cell development in the mouse with limited B cell diversity: role of the antigen receptor signals in the recruitment of B cells to the marginal zone. J Immunol. (2005) 174:1438–45. doi: 10.4049/jimmunol.174.3.1438</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.174.3.1438</ArticleId><ArticleId IdType="pubmed">15661902</ArticleId></ArticleIdList></Reference><Reference><Citation>Pers JO, Devauchelle V, Daridon C, Bendaoud B, Le Berre R, Bordron A, et al. . Baff-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome. Arthritis Rheum. (2007) 56:1464–77. doi: 10.1002/art.22603</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22603</ArticleId><ArticleId IdType="pubmed">17469105</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu HC, Yang P, Wang J, Wu Q, Myers R, Chen J, et al. . Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol. (2008) 9:166–75. doi: 10.1038/ni1552</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1552</ArticleId><ArticleId IdType="pubmed">18157131</ArticleId></ArticleIdList></Reference><Reference><Citation>Doreau A, Belot A, Bastid J, Riche B, Trescol-Biemont M-C, Ranchin B, et al. . Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol. (2009) 10:778–85. doi: 10.1038/ni.1741</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1741</ArticleId><ArticleId IdType="pubmed">19483719</ArticleId></ArticleIdList></Reference><Reference><Citation>Chekol Abebe E, Asmamaw Dejenie T, Mengie Ayele T, Dagnew Baye N, Agegnehu Teshome A, Tilahun Muche Z. The role of regulatory B cells in health and diseases: A systemic review. J Inflammation Res. (2021) 14:75–84. doi: 10.2147/jir.S286426</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/jir.S286426</ArticleId><ArticleId IdType="pmc">PMC7811483</ArticleId><ArticleId IdType="pubmed">33469337</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X, Wang X, Xiao F, Ma K, Liu L, Wang X, et al. . IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sjögren’s syndrome. Cell Mol Immunol. (2019) 16:921–31. doi: 10.1038/s41423-019-0227-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-019-0227-z</ArticleId><ArticleId IdType="pmc">PMC6884445</ArticleId><ArticleId IdType="pubmed">30948793</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao R, Tang J, Dong Y, Ming B, Yu Z, Zhong J, et al. . The aberrant levels of decorin induce damages of human salivary gland epithelial cells and polarization of macrophages. Mod Rheumatol. (2023) 33:557–65. doi: 10.1093/mr/roac034</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/mr/roac034</ArticleId><ArticleId IdType="pubmed">35438773</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng D, Chai J, Wang H, Fu L, Peng S, Ni X. Hepatic macrophages: key players in the development and progression of liver fibrosis. Liver Int. (2021) 41:2279–94. doi: 10.1111/liv.v41.10</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/liv.v41.10</ArticleId><ArticleId IdType="pubmed">33966318</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiguro N, Moriyama M, Furusho K, Furukawa S, Shibata T, Murakami Y, et al. . Activated M2 macrophages contribute to the pathogenesis of IgG4-related disease via toll-like receptor 7/interleukin-33 signaling. Arthritis Rheumatol. (2020) 72:166–78. doi: 10.1002/art.41052</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41052</ArticleId><ArticleId IdType="pmc">PMC6972995</ArticleId><ArticleId IdType="pubmed">31339007</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Gao Z, Zhao L, Du B, Ma B, Nian H, et al. . MSC-derived small extracellular vesicles attenuate autoimmune dacryoadenitis by promoting M2 macrophage polarization and inducing tregs via mIR-100-5p. Front Immunol. (2022) 13:888949. doi: 10.3389/fimmu.2022.888949</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.888949</ArticleId><ArticleId IdType="pmc">PMC9298967</ArticleId><ArticleId IdType="pubmed">35874782</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata K, Moriyama M, Kawado T, Yoshioka H, Yano A, Matsumura-Kawashima M, et al. . Extracellular vesicles of iPS cells highly capable of producing HGF and TGF-Β1 can attenuate Sjögren's syndrome via innate immunity regulation. Cell Signal. (2023) 113:110980. doi: 10.1016/j.cellsig.2023.110980</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2023.110980</ArticleId><ArticleId IdType="pubmed">37981065</ArticleId></ArticleIdList></Reference><Reference><Citation>van Caam A, Vonk M, van den Hoogen F, van Lent P, van der Kraan P. Unraveling SSc pathophysiology; the myofibroblast. Front Immunol. (2018) 9:2452. doi: 10.3389/fimmu.2018.02452</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02452</ArticleId><ArticleId IdType="pmc">PMC6242950</ArticleId><ArticleId IdType="pubmed">30483246</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueno M, Maeno T, Nomura M, Aoyagi-Ikeda K, Matsui H, Hara K, et al. . Hypoxia-inducible factor-1α Mediates TGF-Β-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis. Am J Physiology-Lung Cell Mol Physiol. (2011) 300:L740–L52. doi: 10.1152/ajplung.00146.2010</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00146.2010</ArticleId><ArticleId IdType="pubmed">21239537</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly A, Gunaltay S, McEntee CP, Shuttleworth EE, Smedley C, Houston SA, et al. . Human monocytes and macrophages regulate immune tolerance via integrin Αvβ8–mediated TGFβ Activation. J Exp Med. (2018) 215:2725–36. doi: 10.1084/jem.20171491</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20171491</ArticleId><ArticleId IdType="pmc">PMC6219736</ArticleId><ArticleId IdType="pubmed">30355614</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, Ramirez-Acuña JM, Perez-Romero BA, Guerrero-Rodriguez JF, et al. . The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci. (2020) 21(24):9739. doi: 10.3390/ijms21249739</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21249739</ArticleId><ArticleId IdType="pmc">PMC7767220</ArticleId><ArticleId IdType="pubmed">33419373</ArticleId></ArticleIdList></Reference><Reference><Citation>Skopouli FN, Li L, Boumba D, Stefanaki S, Hanel K, Moutsopoulos HM, et al. . Association of mast cells with fibrosis and fatty infiltration in the minor salivary glands of patients with Sjögren's syndrome. Clin Exp Rheumatol. (1998) 16:63–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">9543564</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti P, Stellin L, Caraffa A, Gallenga CE, Ross R, Kritas SK, et al. . Advances in mast cell activation by IL-1 and IL-33 in Sjögren's syndrome: promising inhibitory effect of IL-37. Int J Mol Sci. (2020) 21(12):4297. doi: 10.3390/ijms21124297</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21124297</ArticleId><ArticleId IdType="pmc">PMC7352728</ArticleId><ArticleId IdType="pubmed">32560266</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel H, Laskawi R, Wahlers A, Hemmerlein B. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1,-2, and-3 in benign and Malignant tumours of the salivary gland. Histopathology. (2004) 44:222–31. doi: 10.1111/j.0309-0167.2004.01814.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0309-0167.2004.01814.x</ArticleId><ArticleId IdType="pubmed">14987225</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa S, Moriyama M, Miyake K, Nakashima H, Tanaka A, Maehara T, et al. . Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease. Sci Rep. (2017) 7:42413. doi: 10.1038/srep42413</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42413</ArticleId><ArticleId IdType="pmc">PMC5304322</ArticleId><ArticleId IdType="pubmed">28205524</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D, Jiang H-R, Kewin P, Li Y, Mu R, Fraser AR, et al. . Il-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci. (2008) 105:10913–8. doi: 10.1073/pnas.0801898105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0801898105</ArticleId><ArticleId IdType="pmc">PMC2491487</ArticleId><ArticleId IdType="pubmed">18667700</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu X, Liu H, Huang G, Dai SS. The emerging role of neutrophils in autoimmune-associated disorders: effector, predictor, and therapeutic targets. MedComm (2020). (2021) 2:402–13. doi: 10.1002/mco2.69</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mco2.69</ArticleId><ArticleId IdType="pmc">PMC8554667</ArticleId><ArticleId IdType="pubmed">34766153</ArticleId></ArticleIdList></Reference><Reference><Citation>Torsteinsdottir I, Gudbjornsson B, Hakansson L. Enhanced neutrophil and eosinophil adhesion in patients with primary Sjogren's syndrome. Clin Exp Rheumatol. (1998) 16:255–62.</Citation><ArticleIdList><ArticleId IdType="pubmed">9631746</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudbjornsson B, Feltelius N, Hallgren R, Venge P. Neutrophil function in patients with primary Sjogren's syndrome: relation to infection propensity. Ann Rheum Dis. (1991) 50:685–90. doi: 10.1136/ard.50.10.685</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.50.10.685</ArticleId><ArticleId IdType="pmc">PMC1004531</ArticleId><ArticleId IdType="pubmed">1958091</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayaprakash K, Demirel I, Khalaf H, Bengtsson T. The role of phagocytosis, oxidative burst and neutrophil extracellular traps in the interaction between neutrophils and the periodontal pathogen porphyromonas gingivalis. Mol Oral Microbiol. (2015) 30:361–75. doi: 10.1111/omi.12099</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/omi.12099</ArticleId><ArticleId IdType="pubmed">25869817</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabarti S, Zee JM, Patel KD. Regulation of matrix metalloproteinase-9 (MMP-9) in TNF-stimulated neutrophils: novel pathways for tertiary granule release. J Leukoc Biol. (2006) 79:214–22. doi: 10.1189/jlb.0605353</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0605353</ArticleId><ArticleId IdType="pubmed">16275891</ArticleId></ArticleIdList></Reference><Reference><Citation>Rischmueller M, Tieu J, Lester S. Primary Sjogren's syndrome. Best Pract Res Clin Rheumatol. (2016) 30:189–220. doi: 10.1016/j.berh.2016.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2016.04.003</ArticleId><ArticleId IdType="pubmed">27421224</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y, Wu X, Zhang S, Deng C, Zhao L, Wang M, et al. . The potential roles of type I interferon activated neutrophils and neutrophil extracellular traps (Nets) in the pathogenesis of primary Sjogren's syndrome. Arthritis Res Ther. (2022) 24:170. doi: 10.1186/s13075-022-02860-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-022-02860-4</ArticleId><ArticleId IdType="pmc">PMC9295258</ArticleId><ArticleId IdType="pubmed">35854322</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Luqmani R, Udalova IA. The role of neutrophils in rheumatic disease-associated vascular inflammation. Nat Rev Rheumatol. (2022) 18:158–70. doi: 10.1038/s41584-021-00738-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00738-4</ArticleId><ArticleId IdType="pubmed">35039664</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, et al. . Nets are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med. (2013) 5:178ra40. doi: 10.1126/scitranslmed.3005580</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3005580</ArticleId><ArticleId IdType="pmc">PMC3727661</ArticleId><ArticleId IdType="pubmed">23536012</ArticleId></ArticleIdList></Reference><Reference><Citation>Su F, Xiao W, Yang P, Chen Q, Sun X, Li T. Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus. Bras Dermatol. (2017) 92:466–9. doi: 10.1590/abd1806-4841.20175476</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/abd1806-4841.20175476</ArticleId><ArticleId IdType="pmc">PMC5595590</ArticleId><ArticleId IdType="pubmed">28954092</ArticleId></ArticleIdList></Reference><Reference><Citation>Konttinen YT, Kangaspunta P, Lindy O, Takagi M, Sorsa T, Segerberg M, et al. . Collagenase in Sjögren's syndrome. Ann Rheum Dis. (1994) 53:836–9. doi: 10.1136/ard.53.12.836</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.53.12.836</ArticleId><ArticleId IdType="pmc">PMC1005486</ArticleId><ArticleId IdType="pubmed">7864694</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein K. In: Fibroblasts in Sjogren's Syndrome, Fibroblasts-Advances in Infammation, Autoimmunity and Cancer. Bertoncelj M. F., Lakota K. editor. (London, UK: IntechOpen; ). (2021).</Citation></Reference><Reference><Citation>Korsunsky I, Wei K, Pohin M, Kim EY, Barone F, Major T, et al. . Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases. Med. (2022) 3:481–518.e14. doi: 10.1016/j.medj.2022.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.05.002</ArticleId><ArticleId IdType="pmc">PMC9271637</ArticleId><ArticleId IdType="pubmed">35649411</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamate J, Iwaki M, Kumagai D, Tsukamoto Y, Kuwamura M, Nakatsuji S, et al. . Characteristics of a rat fibrosarcoma-derived transplantable tumour line (SS) and cultured cell lines (SS-P and SS-A3-1) showing myofibroblastic and histiocytic phenotypes. Virchows Arch. (1997) 431:431–40. doi: 10.1007/s004280050120</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004280050120</ArticleId><ArticleId IdType="pubmed">9428931</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J-C, Lai S, Guo X, Zhang X, de Crombrugghe B, Sonnylal S, et al. . Attenuation of fibrosis in vitro and in vivo with SPARC siRNA. Arthritis Res Ther. (2010) 12:R60. doi: 10.1186/ar2973</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar2973</ArticleId><ArticleId IdType="pmc">PMC2888211</ArticleId><ArticleId IdType="pubmed">20359365</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin JO, Kawai T, Cha S, Yu Q. Interleukin-7 enhances the Th1 response to promote the development of Sjögren's syndrome-like autoimmune exocrinopathy in mice. Arthritis Rheum. (2013) 65:2132–42. doi: 10.1002/art.38007</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38007</ArticleId><ArticleId IdType="pmc">PMC3729733</ArticleId><ArticleId IdType="pubmed">23666710</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Yu Q. Anti-IL-7 receptor-Α Treatment ameliorates newly established Sjögren's-like exocrinopathy in non-obese diabetic mice. Biochim Biophys Acta Mol Basis Dis. (2018) 1864:2438–47. doi: 10.1016/j.bbadis.2018.04.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2018.04.010</ArticleId><ArticleId IdType="pmc">PMC5963292</ArticleId><ArticleId IdType="pubmed">29680668</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Y, Zhang Z, Li J, Luo W, Jiang T, Yang Z. Association between IL-7 and primary Sjögren's syndrome: A single-center study and a systematic scoping review. Int Immunopharmacol. (2022) 108:108758. doi: 10.1016/j.intimp.2022.108758</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2022.108758</ArticleId><ArticleId IdType="pubmed">35405597</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikker A, van Woerkom JM, Kruize AA, Wenting-van Wijk M, de Jager W, Bijlsma JW, et al. . Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation. Arthritis Rheum. (2010) 62:969–77. doi: 10.1002/art.27318</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.27318</ArticleId><ArticleId IdType="pubmed">20131250</ArticleId></ArticleIdList></Reference><Reference><Citation>Manoussakis MN, Kapsogeorgou EK. The role of epithelial cells in the pathogenesis of Sjögren's syndrome. Clin Rev Allergy Immunol. (2007) 32:225–30. doi: 10.1007/s12016-007-8007-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-007-8007-4</ArticleId><ArticleId IdType="pubmed">17992589</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapsogeorgou EK, Tzioufas AG. Interaction of human salivary gland epithelial cells with B lymphocytes: implications in the pathogenesis of Sjögren's syndrome. Mediterr J Rheumatol. (2020) 31:424–6. doi: 10.31138/mjr.31.4.424</Citation><ArticleIdList><ArticleId IdType="doi">10.31138/mjr.31.4.424</ArticleId><ArticleId IdType="pmc">PMC7841102</ArticleId><ArticleId IdType="pubmed">33521577</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura H, Horai Y, Shimizu T, Kawakami A. Modulation of apoptosis by cytotoxic mediators and cell-survival molecules in Sjögren's syndrome. Int J Mol Sci. (2018) 19(8):2369. doi: 10.3390/ijms19082369</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19082369</ArticleId><ArticleId IdType="pmc">PMC6121505</ArticleId><ArticleId IdType="pubmed">30103522</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu P, Ming B, Wu X, Cai S, Tang J, Dong Y, et al. . Intratracheal poly(I:C) exposure accelerates the immunological disorder of salivary glands in Sjogren's-like NOD/ShiLtJ mice. Front Med (Lausanne). (2021) 8:645816. doi: 10.3389/fmed.2021.645816</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.645816</ArticleId><ArticleId IdType="pmc">PMC8076562</ArticleId><ArticleId IdType="pubmed">33928105</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapsogeorgou EK, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN. Salivary gland epithelial cell exosomes: A source of autoantigenic ribonucleoproteins. Arthritis Rheum. (2005) 52:1517–21. doi: 10.1002/art.21005</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.21005</ArticleId><ArticleId IdType="pubmed">15880835</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. (2014) 15:786–801. doi: 10.1038/nrm3904</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3904</ArticleId><ArticleId IdType="pmc">PMC4316204</ArticleId><ArticleId IdType="pubmed">25415508</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel VN, Hoffman MP. Salivary gland development: A template for regeneration. Semin Cell Dev Biol. (2014) 25–26:52–60. doi: 10.1016/j.semcdb.2013.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2013.12.001</ArticleId><ArticleId IdType="pmc">PMC3988231</ArticleId><ArticleId IdType="pubmed">24333774</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinescu ŞC, ForŢofoiu MC, Bumbea AM, Ciurea PL, Busuioc CJ, Muşetescu AE. Histopathological and immunohistochemical profile in primary Sjögren's syndrome. Rom J Morphol Embryol. (2017) 58:409–17.</Citation><ArticleIdList><ArticleId IdType="pubmed">28730224</ArticleId></ArticleIdList></Reference><Reference><Citation>Laine M, Virtanen I, Porola P, Rotar Z, Rozman B, Poduval P, et al. . Acinar epithelial cell laminin-receptors in labial salivary glands in Sjögren's syndrome. Clin Exp Rheumatol. (2008) 26:807–13.</Citation><ArticleIdList><ArticleId IdType="pubmed">19032812</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinkovic M, Tran ON, Wang H, Abdul-Azees P, Dean DD, Chen XD, et al. . Extracellular matrix turnover in salivary gland disorders and regenerative therapies: obstacles and opportunities. J Oral Biol Craniofac Res. (2023) 13:693–703. doi: 10.1016/j.jobcr.2023.08.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jobcr.2023.08.009</ArticleId><ArticleId IdType="pmc">PMC10502366</ArticleId><ArticleId IdType="pubmed">37719063</ArticleId></ArticleIdList></Reference><Reference><Citation>Genç D, Bulut O, Günaydin B, Göksu M, Düzgün M, Dere Y, et al. . Dental follicle mesenchymal stem cells ameliorated glandular dysfunction in Sjögren's syndrome murine model. PloS One. (2022) 17:e0266137. doi: 10.1371/journal.pone.0266137</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0266137</ArticleId><ArticleId IdType="pmc">PMC9070867</ArticleId><ArticleId IdType="pubmed">35511824</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozito TP, Jackson WM, Nesti LJ, Tuan RS. Human mesenchymal stem cells generate a distinct pericellular zone of MMP activities via binding of MMPs and secretion of high levels of TIMPs. Matrix Biol. (2014) 34:132–43. doi: 10.1016/j.matbio.2013.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2013.10.003</ArticleId><ArticleId IdType="pubmed">24140982</ArticleId></ArticleIdList></Reference><Reference><Citation>Maciejczyk M, Pietrzykowska A, Zalewska A, Knaś M, Daniszewska I. The significance of matrix metalloproteinases in oral diseases. Adv Clin Exp Med. (2016) 25:383–90. doi: 10.17219/acem/30428</Citation><ArticleIdList><ArticleId IdType="doi">10.17219/acem/30428</ArticleId><ArticleId IdType="pubmed">27627574</ArticleId></ArticleIdList></Reference><Reference><Citation>Ming B, Zhu Y, Zhong J, Dong L. Immunopathogenesis of Sjogren's syndrome: current state of DAMPs. Semin Arthritis Rheum. (2022) 56:152062. doi: 10.1016/j.semarthrit.2022.152062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2022.152062</ArticleId><ArticleId IdType="pubmed">35803061</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiripolsky J, Kasperek EM, Zhu C, Li Q-Z, Wang J, Yu G, et al. . Immune-intrinsic Myd88 directs the production of antibodies with specificity for extracellular matrix components in primary Sjögren’s syndrome. Front Immunol. (2021) 12:692216. doi: 10.3389/fimmu.2021.692216</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.692216</ArticleId><ArticleId IdType="pmc">PMC8350326</ArticleId><ArticleId IdType="pubmed">34381449</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida K, Wang X, Bhawal UK. Dec1 deficiency restores the age-related dysfunctions of submandibular glands. J Physiol Pharmacol. (2021) 72(4):571–581. doi: 10.26402/jpp.2021.4.09</Citation><ArticleIdList><ArticleId IdType="doi">10.26402/jpp.2021.4.09</ArticleId><ArticleId IdType="pubmed">34987131</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X, Shaw PC, Sze SC, Tong Y, Zhang Y. Dendrobium officinale polysaccharides ameliorate the abnormality of aquaporin 5, pro-inflammatory cytokines and inhibit apoptosis in the experimental Sjögren's syndrome mice. Int Immunopharmacol. (2011) 11:2025–32. doi: 10.1016/j.intimp.2011.08.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2011.08.014</ArticleId><ArticleId IdType="pubmed">21890001</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao L, Ng TB, Feng YB, Yao T, Wong JH, Yao RM, et al. . Dendrobium candidum extract increases the expression of aquaporin-5 in labial glands from patients with Sjögren's syndrome. Phytomedicine. (2011) 18:194–8. doi: 10.1016/j.phymed.2010.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2010.05.002</ArticleId><ArticleId IdType="pubmed">20655712</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivière E, Chivasso C, Pascaud J, Bechara R, Ly B, Delporte C, et al. . Hyperosmolar environment and salivary gland epithelial cells increase extra-cellular matrix remodeling and lymphocytic infiltration in Sjögren’s syndrome. Clin Exp Immunol. (2023) 212:39–51. doi: 10.1093/cei/uxad020</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cei/uxad020</ArticleId><ArticleId IdType="pmc">PMC10081106</ArticleId><ArticleId IdType="pubmed">36759947</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki M, Nakamura S, Ohyama Y, Shinohara M, Ezaki I, Hara H, et al. . Accumulation of common T cell clonotypes in the salivary glands of patients with human T lymphotropic virus type I-associated and idiopathic Sjögren's syndrome. J Immunol. (2000) 164:2823–31. doi: 10.4049/jimmunol.164.5.2823</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.164.5.2823</ArticleId><ArticleId IdType="pubmed">10679126</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh C-C, Wang W-C, Wu C-S, Sung F-C, Su C-T, Shieh Y-H, et al. . Association of Sjögrens syndrome in patients with chronic hepatitis virus infection: A population-based analysis. PloS One. (2016) 11:e0161958. doi: 10.1371/journal.pone.0161958</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0161958</ArticleId><ArticleId IdType="pmc">PMC4999293</ArticleId><ArticleId IdType="pubmed">27560377</ArticleId></ArticleIdList></Reference><Reference><Citation>Barcelos F, Martins C, Monteiro R, Cardigos J, PRussiani T, Sítima M, et al. . Association between EBV serological patterns and lymphocytic profile of SjS patients support a virally triggered autoimmune epithelitis. Sci Rep. (2021) 11:4082. doi: 10.1038/s41598-021-83550-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-83550-0</ArticleId><ArticleId IdType="pmc">PMC7893064</ArticleId><ArticleId IdType="pubmed">33603079</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura H, Shimizu T, Takagi Y, Takahashi Y, Horai Y, Nakashima Y, et al. . Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjögren's syndrome. BMC Musculoskelet Disord. (2015) 16:335. doi: 10.1186/s12891-015-0773-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-015-0773-1</ArticleId><ArticleId IdType="pmc">PMC4634153</ArticleId><ArticleId IdType="pubmed">26537778</ArticleId></ArticleIdList></Reference><Reference><Citation>Björk A, Mofors J, Wahren-Herlenius M. Environmental factors in the pathogenesis of primary Sjögren's syndrome. J Intern Med. (2020) 287:475–92. doi: 10.1111/joim.13032</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13032</ArticleId><ArticleId IdType="pubmed">32107824</ArticleId></ArticleIdList></Reference><Reference><Citation>Kipps TJ, Tomhave E, Chen PP, Fox RI. Molecular characterization of a major autoantibody-associated cross-reactive idiotype in Sjogren's syndrome. J Immunol. (1989) 142:4261–8. doi: 10.4049/jimmunol.142.12.4261</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.142.12.4261</ArticleId><ArticleId IdType="pubmed">2542406</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuka K, Sato M, Tsunematsu T, Ishimaru N. Virus infections play crucial roles in the pathogenesis of Sjogren's syndrome. Viruses. (2022) 14(7):1474. doi: 10.3390/v14071474</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14071474</ArticleId><ArticleId IdType="pmc">PMC9320594</ArticleId><ArticleId IdType="pubmed">35891453</ArticleId></ArticleIdList></Reference><Reference><Citation>Bombardieri M, Barone F, Lucchesi D, Nayar S, van den Berg WB, Proctor G, et al. . Inducible tertiary lymphoid structures, autoimmunity, and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL/6 mice. J Immunol. (2012) 189:3767–76. doi: 10.4049/jimmunol.1201216</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1201216</ArticleId><ArticleId IdType="pmc">PMC3448973</ArticleId><ArticleId IdType="pubmed">22942425</ArticleId></ArticleIdList></Reference><Reference><Citation>Bombardieri M, Pitzalis C. Ectopic lymphoid neogenesis and lymphoid chemokines in Sjogren's syndrome: at the interplay between chronic inflammation, autoimmunity and lymphomagenesis. Curr Pharm Biotechnol. (2012) 13:1989–96. doi: 10.2174/138920112802273209</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920112802273209</ArticleId><ArticleId IdType="pubmed">22208651</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Chavez A, Carrion JA, Forns X, Ramos-Casals M. Extrahepatic manifestations associated with chronic hepatitis C virus infection. Rev Esp Sanid Penit. (2017) 19:87–97. doi: 10.4321/S1575-06202017000300004</Citation><ArticleIdList><ArticleId IdType="doi">10.4321/S1575-06202017000300004</ArticleId><ArticleId IdType="pmc">PMC6241927</ArticleId><ArticleId IdType="pubmed">29364334</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizoguchi I, Ohashi M, Hasegawa H, Chiba Y, Orii N, Inoue S, et al. . EBV-induced gene 3 augments IL-23ralpha protein expression through a chaperone calnexin. J Clin Invest. (2020) 130:6124–40. doi: 10.1172/JCI122732</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI122732</ArticleId><ArticleId IdType="pmc">PMC7598073</ArticleId><ArticleId IdType="pubmed">32809973</ArticleId></ArticleIdList></Reference><Reference><Citation>Jog NR, James JA. Epstein barr virus and autoimmune responses in systemic lupus erythematosus. Front Immunol. (2020) 11:623944. doi: 10.3389/fimmu.2020.623944</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.623944</ArticleId><ArticleId IdType="pmc">PMC7886683</ArticleId><ArticleId IdType="pubmed">33613559</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslinska M, Kostyra-Grabczak K. The role of virus infections in Sjogren's syndrome. Front Immunol. (2022) 13:823659. doi: 10.3389/fimmu.2022.823659</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.823659</ArticleId><ArticleId IdType="pmc">PMC9488556</ArticleId><ArticleId IdType="pubmed">36148238</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeron PB, Retamozo S, Bove A, Kostov BA, Siso A, Ramos-Casals M. Diagnosis of liver involvement in primary Sjogren syndrome. J Clin Transl Hepatol. (2013) 1:94–102. doi: 10.14218/JCTH.2013.00011</Citation><ArticleIdList><ArticleId IdType="doi">10.14218/JCTH.2013.00011</ArticleId><ArticleId IdType="pmc">PMC4521276</ArticleId><ArticleId IdType="pubmed">26355632</ArticleId></ArticleIdList></Reference><Reference><Citation>Maitland N, Flint S, Scully C, Crean SJ. Detection of cytomegalovirus and epstein-barr virus in labial salivary glands in Sjogren's syndrome and non-specific sialadenitis. J Oral Pathol Med. (1995) 24:293–8. doi: 10.1111/j.1600-0714.1995.tb01187.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0714.1995.tb01187.x</ArticleId><ArticleId IdType="pmc">PMC7166772</ArticleId><ArticleId IdType="pubmed">7473264</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura H, Horai Y, Tokuyama A, Yoshimura S, Nakajima H, Ichinose K, et al. . HTLV-I virological and histopathological analysis in two cases of anti-centromere-antibody-seropositive Sjogren's syndrome. Mod Rheumatol. (2013) 23:133–9. doi: 10.1007/s10165-012-0641-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10165-012-0641-x</ArticleId><ArticleId IdType="pubmed">22526828</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura H, Tsukamoto M, Nagasawa Y, Kitamura N, Shimizu T, Kawakami A, et al. . Does HTLV-1 infection show phenotypes found in Sjogren's syndrome? Viruses. (2022) 14(1):100. doi: 10.3390/v14010100</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14010100</ArticleId><ArticleId IdType="pmc">PMC8780498</ArticleId><ArticleId IdType="pubmed">35062304</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera H, Nikitakis NG, Castillo S, Siavash H, Papadimitriou JC, Sauk JJ. Histopathological analysis and demonstration of EBV and HIV p-24 antigen but not CMV expression in labial minor salivary glands of HIV patients affected by diffuse infiltrative lymphocytosis syndrome. J Oral Pathol Med. (2003) 32:431–7. doi: 10.1034/j.1600-0714.2003.00061.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0714.2003.00061.x</ArticleId><ArticleId IdType="pubmed">12846790</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeffers L, Webster-Cyriaque JY. Viruses and salivary gland disease (SGD): lessons from HIV SGD. Adv Dent Res. (2011) 23:79–83. doi: 10.1177/0022034510396882</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022034510396882</ArticleId><ArticleId IdType="pmc">PMC3144046</ArticleId><ArticleId IdType="pubmed">21441486</ArticleId></ArticleIdList></Reference><Reference><Citation>McArthur CP, Africa CW, Castellani WJ, Luangjamekorn NJ, McLaughlin M, Subtil-DeOliveira A, et al. . Salivary gland disease in HIV/AIDS and primary Sjogren's syndrome: analysis of collagen I distribution and histopathology in American and African patients. J Oral Pathol Med. (2003) 32:544–51. doi: 10.1034/j.1600-0714.2003.00159.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0714.2003.00159.x</ArticleId><ArticleId IdType="pubmed">12969229</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi K, Kuwahara H, Fujimoto Y, Nagata K, Takeda J. Severe Covid-19 as a possible mediator of autoimmunity and Sjögren's syndrome. Cureus. (2023) 15:e35290. doi: 10.7759/cureus.35290</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.35290</ArticleId><ArticleId IdType="pmc">PMC10039762</ArticleId><ArticleId IdType="pubmed">36974237</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y, Voigt A, Goranova L, Abed M, Kleiner DE, Maldonado JO, et al. . Evidence of a Sjögren's disease-like phenotype following Covid-19. medRxiv. (2022) 8(24):e166540. doi: 10.1101/2022.10.20.22281265</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.10.20.22281265</ArticleId><ArticleId IdType="pmc">PMC10807711</ArticleId><ArticleId IdType="pubmed">37676726</ArticleId></ArticleIdList></Reference><Reference><Citation>To KK, Tsang OT, Yip CC, Chan KH, Wu TC, Chan JM, et al. . Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. (2020) 71:841–3. doi: 10.1093/cid/ciaa149</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa149</ArticleId><ArticleId IdType="pmc">PMC7108139</ArticleId><ArticleId IdType="pubmed">32047895</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Wei Q, Alvarez X, Wang H, Du Y, Zhu H, et al. . Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques. J Virol. (2011) 85:4025–30. doi: 10.1128/jvi.02292-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02292-10</ArticleId><ArticleId IdType="pmc">PMC3126125</ArticleId><ArticleId IdType="pubmed">21289121</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. (2017) 39:529–39. doi: 10.1007/s00281-017-0629-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0629-x</ArticleId><ArticleId IdType="pmc">PMC7079893</ArticleId><ArticleId IdType="pubmed">28466096</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Wu H, Ding X, Ji H, Jiao P, Song H, et al. . Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis? Med Hypotheses. (2020) 140:109789. doi: 10.1016/j.mehy.2020.109789</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109789</ArticleId><ArticleId IdType="pmc">PMC7194735</ArticleId><ArticleId IdType="pubmed">32361098</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafa OAA, Ibrahim F, Borai E. Protective effects of hesperidin in cyclophosphamide-induced parotid toxicity in rats. Sci Rep. (2023) 13:158. doi: 10.1038/s41598-022-26881-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-26881-w</ArticleId><ArticleId IdType="pmc">PMC9812991</ArticleId><ArticleId IdType="pubmed">36599902</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungureanu LB, Gradinaru I, Ghiciuc CM, Amalinei C, Geletu GL, Petrovici CG, et al. . Atrophy and inflammatory changes in salivary glands induced by oxidative stress after exposure to drugs and other chemical substances: A systematic review. Medicina (Kaunas). (2023) 59(9):1692. doi: 10.3390/medicina59091692</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina59091692</ArticleId><ArticleId IdType="pmc">PMC10535338</ArticleId><ArticleId IdType="pubmed">37763811</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelzaher WY, Nassan MA, Ahmed SM, Welson NN, El-Saber Batiha G, Khalaf HM. Xanthine oxidase inhibitor, febuxostat is effective against 5-fluorouracil-induced parotid salivary gland injury in rats via inhibition of oxidative stress, inflammation and targeting TRPC1/CHOP signalling pathway. Pharm (Basel). (2022) 15(2):232. doi: 10.3390/ph15020232</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15020232</ArticleId><ArticleId IdType="pmc">PMC8880727</ArticleId><ArticleId IdType="pubmed">35215344</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryo K, Yamada H, Nakagawa Y, Tai Y, Obara K, Inoue H, et al. . Possible involvement of oxidative stress in salivary gland of patients with Sjogren's syndrome. Pathobiology. (2006) 73:252–60. doi: 10.1159/000098211</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000098211</ArticleId><ArticleId IdType="pubmed">17314496</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Li Y, Hu J, Wu Y, Yang J, Fan H, et al. . A link between mitochondrial dysfunction and the immune microenvironment of salivary glands in primary Sjogren's syndrome. Front Immunol. (2022) 13:845209. doi: 10.3389/fimmu.2022.845209</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.845209</ArticleId><ArticleId IdType="pmc">PMC8964148</ArticleId><ArticleId IdType="pubmed">35359935</ArticleId></ArticleIdList></Reference><Reference><Citation>Álvarez-Rivas N, Sang-Park H, Díaz del Campo P, Fernández-Castro M, Corominas H, Andreu JL, et al. . Efficacy of belimumab in primary Sjögren's syndrome: A systematic review. Reumatología Clínica. (2021) 17:170–4. doi: 10.1016/j.reuma.2020.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reuma.2020.03.003</ArticleId><ArticleId IdType="pubmed">32451263</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Liu Y, Shi G. Anti-CD20 antibody in primary Sjögren's syndrome management. Curr Pharm Biotechnol. (2014) 15:535–41. doi: 10.2174/138920101506140910150431</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920101506140910150431</ArticleId><ArticleId IdType="pubmed">25213362</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinfeld SD, Tant L, Burmester GR, Teoh NK, Wegener WA, Goldenberg DM, et al. . Epratuzumab (Humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study. Arthritis Res Ther. (2006) 8:R129. doi: 10.1186/ar2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar2018</ArticleId><ArticleId IdType="pmc">PMC1779377</ArticleId><ArticleId IdType="pubmed">16859536</ArticleId></ArticleIdList></Reference><Reference><Citation>Noll B, Mougeot FB, Brennan MT, Mougeot JC. Regulation of MMP9 transcription by ETS1 in immortalized salivary gland epithelial cells of patients with salivary hypofunction and primary Sjögren's syndrome. Sci Rep. (2022) 12:14552. doi: 10.1038/s41598-022-18576-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-18576-z</ArticleId><ArticleId IdType="pmc">PMC9411565</ArticleId><ArticleId IdType="pubmed">36008454</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarode SC, Sharma NK, Sarode G, Sharma M, Radhakrishnan R. Targeting the immune-privileged myofibroblast in oral submucous fibrosis by car T-cell therapy. Med Hypotheses. (2022) 165:110897. doi: 10.1016/j.mehy.2022.110897</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2022.110897</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng X-M, Nikolic-Paterson DJ, Lan HY. TGF-Β: the master regulator of fibrosis. Nat Rev Nephrol. (2016) 12:325–38. doi: 10.1038/nrneph.2016.48</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2016.48</ArticleId><ArticleId IdType="pubmed">27108839</ArticleId></ArticleIdList></Reference><Reference><Citation>Chihaby N, Orliaguet M, Le Pottier L, Pers JO, Boisramé S. Treatment of Sjögren's syndrome with mesenchymal stem cells: A systematic review. Int J Mol Sci. (2021) 22(19):10474. doi: 10.3390/ijms221910474</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910474</ArticleId><ArticleId IdType="pmc">PMC8508641</ArticleId><ArticleId IdType="pubmed">34638813</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Wang D, Liu D, Fan Z, Zhang H, Liu O, et al. . Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome. Blood. (2012) 120:3142–51. doi: 10.1182/blood-2011-11-391144</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-11-391144</ArticleId><ArticleId IdType="pmc">PMC3471521</ArticleId><ArticleId IdType="pubmed">22927248</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan GF, Zheng L, Huang JS, Huang WX, Gong BD, Fang XX, et al. . Effect of mesenchymal stem cells on Sjögren-like mice and the microrna expression profiles of splenic CD4+ T cells. Exp Ther Med. (2017) 13:2828–38. doi: 10.3892/etm.2017.4313</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2017.4313</ArticleId><ArticleId IdType="pmc">PMC5450633</ArticleId><ArticleId IdType="pubmed">28587347</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Helm D, Groenewoud A, de Jonge-Muller ESM, Barnhoorn MC, Schoonderwoerd MJA, Coenraad MJ, et al. . Mesenchymal stromal cells prevent progression of liver fibrosis in a novel zebrafish embryo model. Sci Rep. (2018) 8:16005. doi: 10.1038/s41598-018-34351-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-34351-5</ArticleId><ArticleId IdType="pmc">PMC6207680</ArticleId><ArticleId IdType="pubmed">30375438</ArticleId></ArticleIdList></Reference><Reference><Citation>Du ZH, Ding C, Zhang Q, Zhang Y, Ge XY, Li SL, et al. . Stem cells from exfoliated Deciduous Teeth alleviate hyposalivation caused by Sjögren syndrome. Oral Dis. (2019) 25:1530–44. doi: 10.1111/odi.13113</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/odi.13113</ArticleId><ArticleId IdType="pubmed">31046162</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalili S, Liu Y, Kornete M, Roescher N, Kodama S, Peterson A, et al. . Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sjögren's-like disease. PloS One. (2012) 7:e38615. doi: 10.1371/journal.pone.0038615</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0038615</ArticleId><ArticleId IdType="pmc">PMC3369846</ArticleId><ArticleId IdType="pubmed">22685592</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao G, Qi J, Liang J, Shi B, Chen W, Li W, et al. . Mesenchymal stem cell transplantation alleviates experimental Sjögren's syndrome through IFN-Β/IL-27 signaling axis. Theranostics. (2019) 9:8253–65. doi: 10.7150/thno.37351</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.37351</ArticleId><ArticleId IdType="pmc">PMC6857067</ArticleId><ArticleId IdType="pubmed">31754394</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J, Hong Y, Zhu Q, Zhou H, Zhang Y, Shen Z, et al. . Mesenchymal stem cell enhances the function of MDSCs in experimental Sjögren syndrome. Front Immunol. (2020) 11:604607. doi: 10.3389/fimmu.2020.604607</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.604607</ArticleId><ArticleId IdType="pmc">PMC7782428</ArticleId><ArticleId IdType="pubmed">33414787</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi B, Qi J, Yao G, Feng R, Zhang Z, Wang D, et al. . Mesenchymal stem cell transplantation ameliorates Sjögren's syndrome via suppressing IL-12 production by dendritic cells. Stem Cell Res Ther. (2018) 9:308. doi: 10.1186/s13287-018-1023-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-018-1023-x</ArticleId><ArticleId IdType="pmc">PMC6225717</ArticleId><ArticleId IdType="pubmed">30409219</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyurkchiev D, Bochev I, Ivanova-Todorova E, Mourdjeva M, Oreshkova T, Belemezova K, et al. . Secretion of immunoregulatory cytokines by mesenchymal stem cells. World J Stem Cells. (2014) 6:552–70. doi: 10.4252/wjsc.v6.i5.552</Citation><ArticleIdList><ArticleId IdType="doi">10.4252/wjsc.v6.i5.552</ArticleId><ArticleId IdType="pmc">PMC4178255</ArticleId><ArticleId IdType="pubmed">25426252</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Ma Y, Gao Z, Yang J. Human adipose-derived stem cells inhibit bioactivity of keloid fibroblasts. Stem Cell Res Ther. (2018) 9:40. doi: 10.1186/s13287-018-0786-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-018-0786-4</ArticleId><ArticleId IdType="pmc">PMC5822616</ArticleId><ArticleId IdType="pubmed">29467010</ArticleId></ArticleIdList></Reference><Reference><Citation>Bui TM, Wiesolek HL, Sumagin R. ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. J Leukoc Biol. (2020) 108:787–99. doi: 10.1002/jlb.2mr0220-549r</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jlb.2mr0220-549r</ArticleId><ArticleId IdType="pmc">PMC7977775</ArticleId><ArticleId IdType="pubmed">32182390</ArticleId></ArticleIdList></Reference><Reference><Citation>Kore RA, Wang X, Ding Z, Griffin RJ, Tackett AJ, Mehta JL. MSC exosome-mediated cardioprotection in ischemic mouse heart comparative proteomics of infarct and peri-infarct areas. Mol Cell Biochem. (2021) 476:1691–704. doi: 10.1007/s11010-020-04029-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-020-04029-6</ArticleId><ArticleId IdType="pmc">PMC8186026</ArticleId><ArticleId IdType="pubmed">33423165</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin L, Liu N, Bao C-L-M, Yang D-Z, Ma G-X, Yi W-H, et al. . Mesenchymal stem cells in fibrotic diseases—the two sides of the same coin. Acta Pharmacologica Sin. (2023) 44:268–87. doi: 10.1038/s41401-022-00952-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-022-00952-0</ArticleId><ArticleId IdType="pmc">PMC9326421</ArticleId><ArticleId IdType="pubmed">35896695</ArticleId></ArticleIdList></Reference><Reference><Citation>Salazar KD, Lankford SM, Brody AR. Mesenchymal stem cells produce Wnt isoforms and TGF-Β1 that mediate proliferation and procollagen expression by lung fibroblasts. Am J Physiology-Lung Cell Mol Physiol. (2009) 297:L1002–L11. doi: 10.1152/ajplung.90347.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.90347.2008</ArticleId><ArticleId IdType="pmc">PMC2777498</ArticleId><ArticleId IdType="pubmed">19734317</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-David U, Mayshar Y, Benvenisty N. Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell. (2011) 9:97–102. doi: 10.1016/j.stem.2011.06.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2011.06.013</ArticleId><ArticleId IdType="pubmed">21816361</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang J, Zhang H, Kong W, Deng W, Wang D, Feng X, et al. . Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: A long-term retrospective study. Stem Cell Res Ther. (2018) 9:312. doi: 10.1186/s13287-018-1053-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-018-1053-4</ArticleId><ArticleId IdType="pmc">PMC6236873</ArticleId><ArticleId IdType="pubmed">30428931</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfaifi A, Sultan AS, Montelongo-Jauregui D, Meiller TF, Jabra-Rizk MA. Long-term post-covid-19 associated oral inflammatory sequelae. Front Cell Infect Microbiol. (2022) 12:831744. doi: 10.3389/fcimb.2022.831744</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.831744</ArticleId><ArticleId IdType="pmc">PMC8924417</ArticleId><ArticleId IdType="pubmed">35310855</ArticleId></ArticleIdList></Reference><Reference><Citation>Martonik D, Parfieniuk-Kowerda A, Rogalska M, Flisiak R. The role of Th17 response in covid-19. Cells. (2021) 10(6):1550. doi: 10.3390/cells10061550</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10061550</ArticleId><ArticleId IdType="pmc">PMC8235311</ArticleId><ArticleId IdType="pubmed">34205262</ArticleId></ArticleIdList></Reference><Reference><Citation>Pi P, Zeng Z, Zeng L, Han B, Bai X, Xu S. Molecular mechanisms of covid-19-induced pulmonary fibrosis and epithelial-mesenchymal transition. Front Pharmacol. (2023) 14:1218059. doi: 10.3389/fphar.2023.1218059</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2023.1218059</ArticleId><ArticleId IdType="pmc">PMC10436482</ArticleId><ArticleId IdType="pubmed">37601070</ArticleId></ArticleIdList></Reference><Reference><Citation>Katona K, Farkas N, Kneif M, SütŐ G, Berki T, Balatonyi B, et al. . Image analysis of fibrosis in labial salivary glands of patients with systemic autoimmune diseases. Close correlation of lobular fibrosis to seropositive rheumatoid arthritis and increased anti-CCP and RF titres in the serum. Pathology. (2018) 50:418–25. doi: 10.1016/j.pathol.2017.12.339</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pathol.2017.12.339</ArticleId><ArticleId IdType="pubmed">29735168</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol. (2006) 6:205–17. doi: 10.1038/nri1786</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1786</ArticleId><ArticleId IdType="pubmed">16498451</ArticleId></ArticleIdList></Reference><Reference><Citation>Ainola M, Porola P, Takakubo Y, Przybyla B, Kouri VP, Tolvanen TA, et al. . Activation of plasmacytoid dendritic cells by apoptotic particles - mechanism for the loss of immunological tolerance in Sjögren's syndrome. Clin Exp Immunol. (2018) 191:301–10. doi: 10.1111/cei.13077</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13077</ArticleId><ArticleId IdType="pmc">PMC5801512</ArticleId><ArticleId IdType="pubmed">29105068</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Kubo S, Nakayamada S, Shimajiri S, Zhang X, Yamaoka K, et al. . Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome. Mod Rheumatol. (2016) 26:716–24. doi: 10.3109/14397595.2015.1129694</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/14397595.2015.1129694</ArticleId><ArticleId IdType="pubmed">26706891</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusakiewicz S, Nocturne G, Lazure T, Semeraro M, Flament C, Caillat-Zucman S, et al. . NCR3/NKp30 contributes to pathogenesis in primary Sjögren’s syndrome. Sci Trans Med. (2013) 5:195ra96–ra96. doi: 10.1126/scitranslmed.3005727</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3005727</ArticleId><ArticleId IdType="pmc">PMC4237161</ArticleId><ArticleId IdType="pubmed">23884468</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapsogeorgou EK, Christodoulou MI, Panagiotakos DB, Paikos S, Tassidou A, Tzioufas AG, et al. . Minor salivary gland inflammatory lesions in Sjogren syndrome: do they evolve? J Rheumatol. (2013) 40:1566–71. doi: 10.3899/jrheum.130256</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.130256</ArticleId><ArticleId IdType="pubmed">23908448</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson R, Vogelsang P, Volchenkov R, Espinosa A, Wahren-Herlenius M, Appel S. The complexity of Sjogren's syndrome: novel aspects on pathogenesis. Immunol Lett. (2011) 141:1–9. doi: 10.1016/j.imlet.2011.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2011.06.007</ArticleId><ArticleId IdType="pubmed">21777618</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>